.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Department of Justice
Medtronic
Merck
Teva
Baxter
US Army
Fish and Richardson
Citi
Healthtrust

Generated: December 16, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin glulisine recombinant

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis UsAPIDRAinsulin glulisine recombinantINJECTABLE;IV (INFUSION), SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2500-3310 mL in 1 VIAL, GLASS (0088-2500-33)
Sanofi Aventis UsAPIDRAinsulin glulisine recombinantINJECTABLE;IV (INFUSION), SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2502-055 SYRINGE, PLASTIC in 1 PACKAGE (0088-2502-05) > 3 mL in 1 SYRINGE, PLASTIC
Sanofi Aventis UsAPIDRA SOLOSTARinsulin glulisine recombinantINJECTABLE;SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2500-3310 mL in 1 VIAL, GLASS (0088-2500-33)
Sanofi Aventis UsAPIDRA SOLOSTARinsulin glulisine recombinantINJECTABLE;SUBCUTANEOUS021629NDASanofi-Aventis U.S. LLC0088-2502-055 SYRINGE, PLASTIC in 1 PACKAGE (0088-2502-05) > 3 mL in 1 SYRINGE, PLASTIC
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Daiichi Sankyo
Moodys
Cerilliant
Deloitte
Argus Health
Medtronic
US Army
Johnson and Johnson

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot